查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1208608

2023-2030 年全球口蹄疫疫苗市場

Global Foot and Mouth Disease Vaccines Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

2023 年全球口蹄疫疫苗市場規模預計為 28.743 億美元，預測期內（2023-2030 年）的複合年增長率為 8.6%。

DNA 測試，通常稱為基因測試，是一種醫學測試，可以檢測人類基因、染色體或蛋白質的變化。 這些突變可以揭示一個人是否患有遺傳病。 DNA 測試還可以確定您感染某些疾病或遺傳遺傳問題的風險。 DNA 測試是可選的。 是否接受測試是一個複雜的個人問題，因為測試有其優點、缺點和風險。 遺傳學家或遺傳諮詢師可以通過概述測試的優缺點並檢查其社會和情感影響來提供幫助。

市場動態

推動全球口蹄疫疫苗市場發展的主要因素包括全球對動物產品的需求不斷增長、積極的政府項目、不斷增加的研發支出以及不斷增長的全球動物數量導致了口蹄疫的發展-口病疫苗市場.東西等

全球對畜產品的需求不斷增長預計將推動市場增長。

對牛奶、家禽、雞蛋、紡織品和高科技機械等畜產品的需求不斷增長，正在改變畜牧業並吸引大規模投資。 用於減少動物損失的主要策略之一是接種疫苗。 如果讓受感染的動物死亡，政府和私人動物公司所有者將面臨巨大的經濟損失。 口蹄疫疫苗是必不可少的，因為沒有永久性的治療方法，而且感染的可能性很大。

肉食問題因 2022 年中期世界各地經歷的異常氣候事件而凸顯出來，尤其是創紀錄的高溫和俄羅斯入侵烏克蘭引發的能源危機。 根據 2022 年發表在醫學雜誌《柳葉刀》上的一篇關於英國肉類趨勢的論文，全球人均消費量和總消費量都在增加。 人口增長、財富增加以及重視吃肉的社會文化規範是造成這一激增的原因之一。

根據這篇文章，“不同人群對肉類消費和瘦肉的態度各不相同，以年齡、性別、種族和收入為特徵。” 文章進一步強調，各國內部存在肉類消費的不平等。 最新的糧食及農業組織 (FAO) 糧食展望調查發現，儘管生產環境充滿挑戰，動物疾病流行、衝突和投入成本上升，但 2022 年全球肉類生產將放緩。預計將增加。

高成本預計會阻礙市場增長。

但是，高疫苗儲存成本預計會抑制市場擴張。

COVID-19 影響分析

自 2019 年 12 月爆發 COVID-19 病毒以來，該病已蔓延至 100 多個國家，2020 年 1 月 30 日，世界衛生組織宣布其為突發公共衛生事件。 COVID-19 的經濟影響主要有三方面：對其他藥品和疫苗供需的直接影響、分配系統的中斷以及對製造商的經濟影響。。 包括中國、印度、沙特阿拉伯、阿拉伯聯合酋長國和埃及在內的許多國家普遍實行封鎖，這使得將藥品從一個地方轉移到另一個地方變得困難重重。

但是，COVID-19 大流行損害了全球口蹄疫免疫市場，因為行業巨頭抓住了寶貴的機會來製造可以保護動物的 COVID-19（冠狀病毒）疫苗。 例如，2020 年 4 月，中國生物製藥公司 Sinovac Biotech 的科學家給八隻恆河猴注射了兩劑該公司的 COVID-19 疫苗。 三週後，COVID-19 病毒通過管子穿過猴子的氣管進入猴子的肺部，但沒有人出現全面感染。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 全球對畜產品的需求增加
      • 積極的政府項目
    • 約束因素
      • 高成本預計會阻礙市場增長。
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 常規疫苗
  • 緊急疫苗

第 8 章動物類型

  • 奶牛
  • 山羊
  • 豬
  • 綿羊
  • 其他

第 9 章分銷渠道

  • 獸醫醫院
  • 寵物診所

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第12章公司簡介

  • 勃林格殷格翰國際有限公司
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Merck and Co., Inc
  • China Agricultural Vet. Bio. Science and Technology
  • Biogenesis Bago SA
  • Indian Immunologicals Ltd
  • Vecol S.A.
  • Brilliant Bio Pharma Private Limited
  • Limor de Colombia
  • FGBI-ARRIAH
  • QYH Biotech.

第13章 DataM

簡介目錄
Product Code: DMVH1523

Market Overview

The global foot and mouth disease vaccines market size was valued at US$ 2,874.3 million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 8.6% during the forecast period (2023-2030).

A DNA test, often known as genetic testing, is a medical examination that can spot changes in human genes, chromosomes, or proteins. These mutations can reveal if a person has a genetic disorder or not. DNA tests can also determine a person's risk of contracting a certain illness or passing along a genetic problem. Testing for DNA is optional. Whether to be tested is complex and personal because there are advantages to testing and drawbacks and risks. A geneticist or genetic counselor can assist by outlining the advantages and disadvantages of the test and by going over its social and emotional implications.

Market Dynamics

The major factors driving the global foot and mouth disease vaccines market the the rise in the global demand for animal products, positive governmental projects, increasing research and development spending, and the foot and mouth disease vaccine market will develop as the animal population increases globally.

The rise in the global demand for animal products is expected to drive the market's growth.

The growing demand for animal goods, including milk, chicken, eggs, mefabrics, andl as high-tech machinery, are some drivers changing the animal business and luring massive investment. One of the main strategies used to reduce animal loss is vaccination. Governments and private animal company owners risk suffering significant financial losses if affected animals are put to death. Due to the lack of a permanent treatment and the numerous ways in which contamination might happen, the FMD vaccine is essential.

The issue of meat eating has come up due to the extraordinary climatic occurrences experienced around the world in mid-2022, most notably record-high temperatures and the energy crisis brought on by Russia's invasion of Ukraine. According to a 2022 article on meat trends in the U.K. published in the medical journal The Lancet, the average quantity of meat consumed per person and the total amount consumed is increasing globally. Population expansion increased wealth, and sociocultural norms that place a high value on eating meat are all blamed for this surge.

According to the article, "attitudes towards meat consumption and meat reduction differ within segments of the population, as characterized by age, gender, ethnicity, or income." The article goes on to underline that inequalities in meat consumption also exist within countries. The newest Food Outlook study from the U.N. Food and Agriculture Organization (FAO) predicts that global meat output will increase moderately in 2022, despite a difficult production environment characterized by widespread animal illnesses, conflicts, and rising input costs.

Expensive cost is expected to hamper the market's growth.

However, high vaccine storage costs are anticipated to restrain market expansion.

COVID-19 Impact Analysis

The disease has spread to over 100 nations since the COVID-19 viral epidemic in December 2019, and on January 30, 2020, the World Health Organization proclaimed it a public health emergency. The three primary ways that COVID-19 can affect the economy include directly impacting the supply and demand for other medications and vaccines, causing disruptions in the distribution system, and having an economic impact on manufacturers. Many nations, including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and others, have difficulty moving pharmaceuticals from one location to another due to widespread lockdowns.

The COVID-19 pandemic, however, harms the global market for foot and mouth disease vaccinations since major firms in the industry are grabbing value-grab chances to create COVID-19 (coronavirus) vaccines that can protect animals. For instance, in April 2020, scientists from the Chinese biopharmaceutical company Sinovac Biotech Ltd. administered two doses of its COVID-19 vaccine to eight rhesus macaques. The COVID-19 virus was inserted into the monkeys' lungs through tubes down their tracheas three weeks later, but none developed a full-blown infection.

Segment Analysis

The cattle segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The animal type segment is the highest market holder in the global foot and mouth disease vaccines market. The huge population of cattle worldwide and the domination of cattle farming as a major source of income for people in many nations are the main causes of the rise of the livestock segment. For instance, the likelihood of contracting an infection would be higher in nations with big cattle populations, such as China and Mexico. The Food and Agriculture Organization (FAO) predicted in September 2021 that India's national herd would increase by 1.2 million head from the Italy cattle count in 2021 to reach 306.7 million animals in 2022.

One of the most contagious illnesses in cattle is FMD. It threatens the world's cow population and has resulted in significant financial losses. Although this disease was successfully eradicated in the U.S. in 1929, several other nations are currently engaged in this conflict. The market growth may be boosted by OIE (World Organization for Animal Health) campaigns like the Southeast Asia Foot and Mouth Disease Campaign (SEAFMDC).

The introduction of immunization programs for cattle by various organizations is also anticipated to fuel the segment's expansion. For instance, the Prayagraj animal husbandry began a huge campaign to immunize cows and other cattle against foot and mouth disease in August 2020. Due to the rising demand for better and healthier meat, there is growing awareness of zoonoses and diseases affecting cattle. Therefore, these variables will have a favorable impact on the market in the years to come.

Geographical Analysis

North America holds the largest market share in the global Foot And Mouth Disease Vaccines market.

North America dominates the global foot and mouth disease vaccines market primarily due to excellent medical infrastructure, and high-income levels. Due to the widespread implementation of benefits for animal healthcare in the region, the North American region is one of the largest contributors to the vaccine market against foot and mouth disease. A combination of sophisticated animal healthcare programs and increased public awareness of animal health is expected to fuel the market's rapid growth in the region.

Additionally, the prevalence of animal diseases is driving up the demand for quick and efficient treatment alternatives, which is anticipated to drive the market's growth over the forecast period. For instance, it was indicated in the December 2021 article titled "Foreign animal disease concern: foot and mouth disease" that foot and mouth disease was a condition that needed to be reported in the United States. Foot and mouth disease decimates the cattle business in the U.S. and results in catastrophic losses that harm the economy and animal welfare. Foot and mouth disease's impact on animal welfare is anticipated to increase demand for efficient immunization.

Additionally, it is anticipated that several market players will continue to create new products, fueling the market's expansion in this area. To permit the production of the foot and mouth disease vaccine in the United States, for instance, Zoetis, Inc. submitted a petition to the Animal and Plant Health Inspection Services in August 2020. Thus, it is anticipated that the abovementioned elements will fuel market expansion in this area during the projection year.

Competitive Landscape

The foot and mouth disease vaccines market is moderately competitive with local and global companies' presence. Boehringer Ingelheim International GmbH, Merck and Co., Inc, China Agricultural Vet. Bio. Science and Technology, Biogenesis Bago SA, Indian Immunologicals Ltd

Vecol S.A., Brilliant Bio Pharma Private Limited, Limor de Colombia, FGBI-ARRIAH, QYH Biotech and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in October 2022,a new animal vaccine production plant is being built in Hyderabad by Indian Immunologicals (IIL), a division of the National Dairy Development Board (NDDB), with an investment of Rs 700 crore. The facility's ability to produce 600 million annual doses of the Foot and Mouth disease (FMD) vaccine will be doubled.

Boehringer Ingelheim International GmbH.

Overview: A division of CH Boehringer Sohn AG & Co KG, Boehringer Ingelheim International GmbH (Boehringer) is a pharmaceutical firm that develops, produces, and sells medicines, parasiticides, vaccines, and therapies for unmet medical needs. It provides a wide range of products, including biopharmaceuticals, animal health care items, and treatments for human ailments. The company's medications are used, among other things, to treat diseases of the immune system, the cardiovascular and metabolic systems, the respiratory system, cancer, and the retina. Additionally, it provides animal healthcare items for pigs, ruminants, poultry, horses, and other species.

Product Portfolio:

Aftopor: Aftopor, Aftovaxpur, and Aftobov Oleosa, three FMD vaccines with highly powerful and purified antigens, may offer marker features that allow difference between infected and vaccinated animals (DIVA) for endemic or emergency situations. Only use Aftovaxpur Doe in dire circumstances.

The global Foot And Mouth Disease Vaccines market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the global demand for animal products
      • 4.1.1.2. Positive governmental projects.
    • 4.1.2. Restraints:
      • 4.1.2.1. Expensive cost is expected to hamper the market's growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Conventional Vaccines
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Emergency Vaccines

8. By Animal Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 8.1.2. Market Attractiveness Index, By Animal Type
  • 8.2. Cattle
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Goat
  • 8.4. Pig
  • 8.5. Sheep
  • 8.6. Others

9. By Distribution Channel

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.1.2. Market Attractiveness Index, By Distribution Channel
  • 9.2. Veterinary Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Pet Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size AnalysisUS$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Animal Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Boehringer Ingelheim International GmbH
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Merck and Co., Inc
  • 12.3. China Agricultural Vet. Bio. Science and Technology
  • 12.4. Biogenesis Bago SA
  • 12.5. Indian Immunologicals Ltd
  • 12.6. Vecol S.A.
  • 12.7. Brilliant Bio Pharma Private Limited
  • 12.8. Limor de Colombia
  • 12.9. FGBI-ARRIAH
  • 12.10. QYH Biotech.

LIST NOT EXHAUSTIVE

13. Global Foot And Mouth Disease Vaccines Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us